Variant report
Variant | nsv823063 |
---|---|
Chromosome Location | chr5:43784501-43786658 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553500774 | chr5:43784543-43784544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551647040 | chr5:43784581-43784582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112375856 | chr5:43784590-43784591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573469661 | chr5:43784616-43784617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181195888 | chr5:43784690-43784691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557507025 | chr5:43784731-43784732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138546165 | chr5:43784744-43784745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377055613 | chr5:43784747-43784748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577549396 | chr5:43784769-43784770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543568301 | chr5:43784776-43784777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557112041 | chr5:43784791-43784792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571873994 | chr5:43784800-43784801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539184011 | chr5:43784824-43784825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150187986 | chr5:43784838-43784839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187112412 | chr5:43784871-43784872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375868170 | chr5:43784909-43784910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528421084 | chr5:43784931-43784932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557263834 | chr5:43784935-43784936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190499464 | chr5:43784993-43784994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565170974 | chr5:43784996-43784997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183456998 | chr5:43785077-43785078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35414768 | chr5:43785109-43785110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138856309 | chr5:43785115-43785116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567439442 | chr5:43785119-43785120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537377183 | chr5:43785130-43785131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530096684 | chr5:43785132-43785133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78934920 | chr5:43785214-43785215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546883776 | chr5:43785239-43785240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567053993 | chr5:43785277-43785278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532625368 | chr5:43785296-43785297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376712726 | chr5:43785300-43785301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4348224 | chr5:43785365-43785366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186285588 | chr5:43785367-43785368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35023467 | chr5:43785387-43785388 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs537057410 | chr5:43785388-43785389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556955302 | chr5:43785419-43785420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183003650 | chr5:43785430-43785431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542739394 | chr5:43785439-43785440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552931694 | chr5:43785463-43785464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572978835 | chr5:43785492-43785493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187535628 | chr5:43785499-43785500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74990615 | chr5:43785540-43785541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530684752 | chr5:43785599-43785600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551423573 | chr5:43785605-43785606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558981106 | chr5:43785616-43785617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544211092 | chr5:43785623-43785624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560902366 | chr5:43785627-43785628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530181560 | chr5:43785637-43785638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72760500 | chr5:43785673-43785674 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs566979465 | chr5:43785754-43785755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Lung cancer | 21569311 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:43771400-43785000 | Weak transcription | Fetal Stomach | stomach |
2 | chr5:43785000-43785800 | Enhancers | Fetal Stomach | stomach |
3 | chr5:43785200-43785600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr5:43785200-43785600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr5:43785200-43785600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr5:43785200-43785600 | Enhancers | Stomach Smooth Muscle | stomach |
7 | chr5:43785200-43785800 | Enhancers | Psoas Muscle | Psoas |
8 | chr5:43785600-43789400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |